Report Detail

Request for Sample of this report

Pharma & Healthcare Global Systemic Lupus Erythematosus (SLE) Drugs Market Research Report 2019

  • RnM3108432
    • |
  • 12 March, 2019
    • |
  • Global
    • |
  • 97 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of flare-ups and remissions and can range from mild to life threatening in severity. No cure for SLE yet exists.
Global Systemic Lupus Erythematous (SLE) Drugs market is projected to grow due to high prevalence of autoimmune diseases particularly systemic lupus erythematous (SLE). Major drivers for global systemic erythematous drugs market are development of novel SLE therapies, increasing availability of bio similar drugs and increasing support for emerging research areas for new drug molecules. At the same time, increasing awareness of disease diagnosis and treatment as well as consistent research and development processes for novel drug molecules are important drivers for global lupus erythematous market. Additionally, safety and quality of systemic lupus erythematous controlling therapy may possibly be a challenge for the growth of the global systemic lupus erythematous drugs market. Moreover, numerous public awareness programs targeted to increase awareness levels are also being accompanied. For instance, Lupus Foundation of America (LFA) has been implementing various projects to increase central support for SLE research and services to support people and families affected by SLE. However, serious side effectswith steroids, sensitivity with antibiotics, limited usage of Benlysta for severe SLE patients, and stringent regulatory approvals for new treatment options with better levels of efficacy and safety are obstructing the global systemic lupus erythematous drugs market.

The global Systemic Lupus Erythematosus (SLE) Drugs market is valued at 170 million US$ in 2018 is expected to reach 280 million US$ by the end of 2025, growing at a CAGR of 6.8% during 2019-2025.
This report focuses on Systemic Lupus Erythematosus (SLE) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Systemic Lupus Erythematosus (SLE) Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Anthera Pharmaceuticals
GSK
ImmuPharma
Johnson & Johnson
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Corticosteroids
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Anti-Inflammatories
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Antimalarials
BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS)
Immunosuppressive Agents/Immune Modulators
Anticoagulants

Segment by Application
Intravenous
Sub-Cutaneous
Oral
Topical


Table of Contents

    Executive Summary

      1 Systemic Lupus Erythematosus (SLE) Drugs Market Overview

      • 1.1 Product Overview and Scope of Systemic Lupus Erythematosus (SLE) Drugs
      • 1.2 Systemic Lupus Erythematosus (SLE) Drugs Segment by Type
        • 1.2.1 Global Systemic Lupus Erythematosus (SLE) Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Corticosteroids
        • 1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
        • 1.2.4 Anti-Inflammatories
        • 1.2.5 Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
        • 1.2.6 Antimalarials
        • 1.2.7 BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS)
        • 1.2.8 Immunosuppressive Agents/Immune Modulators
        • 1.2.9 Anticoagulants
      • 1.3 Systemic Lupus Erythematosus (SLE) Drugs Segment by Application
        • 1.3.1 Systemic Lupus Erythematosus (SLE) Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Intravenous
        • 1.3.3 Sub-Cutaneous
        • 1.3.4 Oral
        • 1.3.5 Topical
      • 1.4 Global Systemic Lupus Erythematosus (SLE) Drugs Market by Region
        • 1.4.1 Global Systemic Lupus Erythematosus (SLE) Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Systemic Lupus Erythematosus (SLE) Drugs Market Size
        • 1.5.1 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue (2014-2025)
        • 1.5.2 Global Systemic Lupus Erythematosus (SLE) Drugs Production (2014-2025)

      2 Global Systemic Lupus Erythematosus (SLE) Drugs Market Competition by Manufacturers

      • 2.1 Global Systemic Lupus Erythematosus (SLE) Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Systemic Lupus Erythematosus (SLE) Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Systemic Lupus Erythematosus (SLE) Drugs Production Sites, Area Served, Product Types
      • 2.5 Systemic Lupus Erythematosus (SLE) Drugs Market Competitive Situation and Trends
        • 2.5.1 Systemic Lupus Erythematosus (SLE) Drugs Market Concentration Rate
        • 2.5.2 Systemic Lupus Erythematosus (SLE) Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Systemic Lupus Erythematosus (SLE) Drugs Production Market Share by Regions

      • 3.1 Global Systemic Lupus Erythematosus (SLE) Drugs Production Market Share by Regions
      • 3.2 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Systemic Lupus Erythematosus (SLE) Drugs Production
        • 3.4.1 North America Systemic Lupus Erythematosus (SLE) Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Systemic Lupus Erythematosus (SLE) Drugs Production
        • 3.5.1 Europe Systemic Lupus Erythematosus (SLE) Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Systemic Lupus Erythematosus (SLE) Drugs Production (2014-2019)
        • 3.6.1 China Systemic Lupus Erythematosus (SLE) Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Systemic Lupus Erythematosus (SLE) Drugs Production (2014-2019)
        • 3.7.1 Japan Systemic Lupus Erythematosus (SLE) Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Systemic Lupus Erythematosus (SLE) Drugs Consumption by Regions

      • 4.1 Global Systemic Lupus Erythematosus (SLE) Drugs Consumption by Regions
      • 4.2 North America Systemic Lupus Erythematosus (SLE) Drugs Consumption (2014-2019)
      • 4.3 Europe Systemic Lupus Erythematosus (SLE) Drugs Consumption (2014-2019)
      • 4.4 China Systemic Lupus Erythematosus (SLE) Drugs Consumption (2014-2019)
      • 4.5 Japan Systemic Lupus Erythematosus (SLE) Drugs Consumption (2014-2019)

      5 Global Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Systemic Lupus Erythematosus (SLE) Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Systemic Lupus Erythematosus (SLE) Drugs Price by Type (2014-2019)
      • 5.4 Global Systemic Lupus Erythematosus (SLE) Drugs Production Growth by Type (2014-2019)

      6 Global Systemic Lupus Erythematosus (SLE) Drugs Market Analysis by Applications

      • 6.1 Global Systemic Lupus Erythematosus (SLE) Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Systemic Lupus Erythematosus (SLE) Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Systemic Lupus Erythematosus (SLE) Drugs Business

      • 7.1 Anthera Pharmaceuticals
        • 7.1.1 Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Production Sites and Area Served
        • 7.1.2 Systemic Lupus Erythematosus (SLE) Drugs Product Introduction, Application and Specification
        • 7.1.3 Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 GSK
        • 7.2.1 GSK Systemic Lupus Erythematosus (SLE) Drugs Production Sites and Area Served
        • 7.2.2 Systemic Lupus Erythematosus (SLE) Drugs Product Introduction, Application and Specification
        • 7.2.3 GSK Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 ImmuPharma
        • 7.3.1 ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Production Sites and Area Served
        • 7.3.2 Systemic Lupus Erythematosus (SLE) Drugs Product Introduction, Application and Specification
        • 7.3.3 ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Johnson & Johnson
        • 7.4.1 Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Production Sites and Area Served
        • 7.4.2 Systemic Lupus Erythematosus (SLE) Drugs Product Introduction, Application and Specification
        • 7.4.3 Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served

      8 Systemic Lupus Erythematosus (SLE) Drugs Manufacturing Cost Analysis

      • 8.1 Systemic Lupus Erythematosus (SLE) Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Systemic Lupus Erythematosus (SLE) Drugs
      • 8.4 Systemic Lupus Erythematosus (SLE) Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Systemic Lupus Erythematosus (SLE) Drugs Distributors List
      • 9.3 Systemic Lupus Erythematosus (SLE) Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Systemic Lupus Erythematosus (SLE) Drugs Market Forecast

      • 11.1 Global Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue Forecast
        • 11.1.1 Global Systemic Lupus Erythematosus (SLE) Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Systemic Lupus Erythematosus (SLE) Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Systemic Lupus Erythematosus (SLE) Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Systemic Lupus Erythematosus (SLE) Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Systemic Lupus Erythematosus (SLE) Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Systemic Lupus Erythematosus (SLE) Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Systemic Lupus Erythematosus (SLE) Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Systemic Lupus Erythematosus (SLE) Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Systemic Lupus Erythematosus (SLE) Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Systemic Lupus Erythematosus (SLE) Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Systemic Lupus Erythematosus (SLE) Drugs. Industry analysis & Market Report on Systemic Lupus Erythematosus (SLE) Drugs is a syndicated market report, published as Global Systemic Lupus Erythematosus (SLE) Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Systemic Lupus Erythematosus (SLE) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        		$2,900.00
        		$4,350.00
        		$5,800.00
        		2,241.70
        		3,362.55
        		4,483.40
        		2,699.90
        		4,049.85
        		5,399.80
        		442,801.00
        		664,201.50
        		885,602.00
        		244,760.00
        		367,140.00
        		489,520.00
        Credit card Logo
        Sample Question Discount Download PDF

        Related Reports

        Reason to Buy

        • Trusted By Leaders

          Top executives from leading companies purchase research reports from us. 

        • Shop With Confidence

          We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

        • Customer Centric

          Need assistance related to your research requirements? We are just a phone call or an email away.

        • Personalized Solutions

          Our experienced research specialists are here to help you locate the right reports for your need.

        • Secure Checkout

          Shop without being worried about safety & security of your transactions.
          •

        Request for Sample of this report

        Reports and Markets

        mcafree

        Contact Us

        +1-352-353-0818 (US)

        info@reportsandmarkets.com

        Support

        EMAIL US

        Newsletter

        KEEP UP TO DATE ON ALL THE LATEST REPORTS


        maxmind_logo